000 01388 a2200349 4500
005 20250515140044.0
264 0 _c20090106
008 200901s 0 0 eng d
022 _a1532-2084
024 7 _a10.1016/j.drup.2008.08.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcConkey, David J
245 0 0 _aMechanisms of proteasome inhibitor action and resistance in cancer.
_h[electronic resource]
260 _bDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
_c
300 _a164-79 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCysteine Proteinase Inhibitors
_xtherapeutic use
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aHumans
650 0 4 _aNF-kappa B
_xmetabolism
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProteasome Endopeptidase Complex
_xmetabolism
650 0 4 _aProteasome Inhibitors
650 0 4 _aProtein Folding
_xdrug effects
650 0 4 _aTreatment Outcome
700 1 _aZhu, Keyi
773 0 _tDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
_gvol. 11
_gno. 4-5
_gp. 164-79
856 4 0 _uhttps://doi.org/10.1016/j.drup.2008.08.002
_zAvailable from publisher's website
999 _c18285196
_d18285196